YY/T 0918-2014Test method for determining bacterial retention of membrane/filter assembly utilized for infusion liquid filtration (English PDF)
药液过滤膜、药液过滤器细菌截留试验方法
This is a limited preview
Buy now to download the full PDF (19 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0918-2014 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 17, 2014
Implementation date
July 1, 2015
Scope
YY/T 0918-2014 is the English-translated version of 药液过滤膜、药液过滤器细菌截留试验方法.
YY/T 0918-2014 is the Chinese pharmaceutical industry standard that gives the test method for determining the bacterial retention of the membrane or filter assembly used to filter an infusion liquid, by which a filter is shown to be of sterilizing grade.
It sets out the challenge organism and its suspension, the conditions and the pressure of the filtration, the volume filtered per unit area, the recovery and counting of any organisms that pass and the way the retention is reported. Issued on 17 June 2014, it has applied since 1 July 2015.
Found what you need?
Document preview — YY/T 0918-2014
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- Introduction4
- 1 Scope5
- 2 Normative references5
- 3 Terms and definitions5
- 4 Overview of test method5
- 5 Significance and use6
- 6 Apparatuses6
- 7 Purity of reagents and materials7
- 8 Reagents and materials8
- 9 Preparation method of bacterial challenge stock solution9
- 10 Identification of Brevundimonas diminuta11
- 11 Preparation of bacterial challenge suspension12
- 12 Sample and instrument preparation13
- 13 Test steps14
- 14 Result expression15
- Appendix A (Informative) Liquid filtration membrane/filter bacterial retention cycle test plan17
- Bibliography19
1 Scope
Test method specified in this Standard applies to the evaluation of bacterial retention of sterilizing-grade membranes or filter assemblies utilized for infusion liquid filtration for medical devices with a nominal pore size not exceeding 0.22 µm.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.
GB/T 6682, Water for analytical laboratory use - Specification and test methods
YY/T 0929.1, Sterilizing-grade filters for medical infusion equipment - Part 1: Integrity test for fluid filters
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1 log reduction value; LRV
The 10-base logarithm of the ratio of the number of challenge microorganisms to the number of filtrate microorganisms.
4 Overview of test method
Use a certain volume and concentration of Brevundimonas diminuta (ATCC 19146) bacterial suspension - at a pressure difference of no more than 200 kPa on both sides of the membrane and a flow rate of 2 mL/min ~ 4 mL/min per square centimeter of effective filtration area (EFA) - to challenge the sterilized membrane or filter assembly for testing, so that the final challenge level is not less than 107 CFU/cm2 EFA. After all the filtrate is filtered through the analytical filter membrane, place the analytical filter membrane on the solid culture medium for culture. Bacteria that are able to pass through the test filter membrane or filter assembly will form visible colonies on the analytical filter, which can be counted.
Note: When it is necessary to assess whether the filter membrane or filter assembly can maintain its bacterial retention ability after long-term use, the test plan given in Appendix A can be used.
5 Significance and use
5.1 This test method is designed to evaluate the bacterial retention ability of sterilizing-grade filter membrane or filter assembly under clinical use conditions.
5.2 The challenge level per square centimeter of effective filtration area to withstand 107 of bacteria is much higher than the general sterilization filtration process. This challenge level is selected to provide a high degree of safety guarantee that the filter membrane or filter assembly can retain a large number of microorganisms.
6 Apparatuses
6.3 47 mm filter device, connected by hose.
6.4 Diaphragm-protected pressure gauge, with suitable measuring range.
6.6 Pipeline, resistant to high pressure steam, be capable of withstanding a pressure of 350 kPa.
6.9 Biochemical incubator, 30 °C ± 2 °C
6.5 Valve, resistant to high pressure steam, connected by hose
6.1 Stainless steel pressure vessel
6.2 Air conditioner
6.7 Liquid flow meter
6.8 Hose clamp
6.10 Biological safety cabinet
6.11 Ultra-clean workbench
The instrument assembly is shown in Figure 1.
8 Reagents and materials
8.2.5 Tryptic soy broth
Prepare according to manufacturer's instructions.
8.3 Analytical reagents and materials
8.3.1 M plate count agar
Prepare according to manufacturer's instructions.
8.3.2 Peptone water (1 g/L)
Dissolve the peptone into water; distribute it into screw-top bottles in appropriate volumes to prepare a 10-fold dilution; sterilize at 121 °C for 15 minutes.
8.4 Brevundimonas diminuta
Brevundimonas diminuta (ATCC 19146).
8.5 Analytical membrane
Diameter 47 mm, pore size 0.45 µm.
9 Preparation method of bacterial challenge stock solution
9.1 General
The following two methods have been widely used for the preparation of Brevundimonas diminuta suspensions. These methods are not exclusive of other equally effective methods. However, it is important that all Brevundimonas diminuta challenge suspensions used are monodisperse and comply with the provisions of Chapter 10.
9.2 Isolation and preservation of strains
Culture according to the instructions for Brevundimonas diminuta and check purity by the streak plate. Check whether the colony morphology is consistent and identify single colonies of Brevundimonas diminuta according to Chapter 10.
9.2.1 Stock cultures
Prepare the stock culture from the single colony isolated in 9.2. Inoculate tryptic soy agar slant and culture at 30 °C ± 2 °C for 24 h. Use sterile liquid paraffin to cover the slant and store at 4 °C. Check viability and purity weekly. Alternatively, tryptic soy semi-solid agar stab can be used instead of slant culture.
9.2.2 Long-term storage of cultures
Freeze-dry or store in liquid nitrogen.
9.3 Preparation of challenge stocks in saline lactose broth
9.3.1 Inoculate stock culture (9.2.1) into10 mL of sterile tryptic soy broth and culture it at 30 °C ± 2 °C for 24 hours.
9.3.2 Transfer 2 mL of the well-mixed broth culture solution into 1 L of sterile saline lactose broth; vortex to mix; incubate at 30 °C ± 2 °C for 24 hours.
Note: The bacterial suspension in saline lactose broth can be stored at 4 °C before use, for no more than 8 hours.
9.3.3 Determine the concentration of viable bacteria in the challenge bacterial suspension according to Chapter 11 (general concentration 107 CFU/mL ~ 108 CFU/mL).
9.3.4 Identify Brevundimonas diminuta according to Chapter 10
9.4 Preparation of Brevundimonas diminuta frozen bacteria paste
9.4.1 Inoculate stock culture (9.2.1) into 10 mL of sterile growth medium A (8.2.1) and culture it at 30 °C ± 2 °C for 24 hours.
9.4.2 Transfer 10 mL of the bacterial suspension obtained in 9.4.1 into 500 mL of sterile growth medium A, and incubate at 30 °C ± 2 °C for 24 hours.
9.4.3 Transfer 200 mL of the bacterial suspension obtained in 9.4.2 into 10 L of sterile growth medium A; prepare 10 L of seed culture solution; culture at 30 °C ± 2 °C for 24 hours.
9.4.5 When the culture reaches the stationary growth phase, collect the bacterial cells by continuous centrifugation.
9.4.6 Resuspend the bacterial cells in 2 ~ 3 times the volume of cold sterile buffer for storage.
9.4.7 Centrifuge the bacterial cell suspension and resuspend the bacterial cells in an equal volume of buffer for storage. Determine the bacterial concentration (viable bacterial concentration is generally 1 x 10^12 CFU/mL).
9.4.8 Transfer all the bacterial paste (such as 50 mL) into a sterile plastic centrifuge tube, use dry ice acetone or liquid nitrogen to freeze it; store it at -60 °C.
9.4.4 Inoculate the above 10 L of seed culture solution into 500 L of growth medium
A Incubate aerobically at 30 °C ± 2 °C. Monitor growth by spectrophotometric analysis at 500 nm and draw a growth curve.
9.5 Preparation of challenge stock solution by frozen strain paste
9.5.1 Use sterile forceps to clamp the test tube; immerse it in 80% (volume fraction) alcohol for disinfection; ignite the alcohol until most of the alcohol is burned out.
9.5.2 Aseptically remove the test tube cap; under normal temperature conditions, put the test tube into a conical flask containing a sterile magnetic stirring rod and stroke-physiological saline solution - containing 0.001 mol/L ~ 0.002 mol/L magnesium chloride (MgCl2) - of 20 times the volume of bacterial paste (for example, transfer 50 mL of frozen bacterial paste into 1 L of sterile solution).
Note: Magnesium chloride (MgCl2) needs to be dissolved in the solvent before adding the frozen bacteria paste.
9.5.3 Place the flask on the magnetic stirrer and mix until the contents in the test tube are evenly suspended (40 minutes).
9.5.4 Determine the viable bacterial concentration according to Chapter 11 (bacterial suspension concentration is generally 1 x 10^10 CFU/mL ~ 2 x 10^10 CFU/mL).
9.5.5 Identify Brevundimonas diminuta according to Chapter 10
10 Identification of Brevundimonas diminuta
10.1 Colony morphology
10.1.1 The colonies of Brevundimonas diminuta are beige, slightly raised, and completely transparent.
10.1.2 After culturing at 30 °C (optimal growth temperature) for 24 hours, it grows to the size of a needle tip, and the diameter will be 1 mm ~ 2 mm after cultivating for 36 h ~ 48 h.
10.2 Microscopic observation
10.2.2 Perform flagella staining (optional). Brevundimonas diminuta is characterized by polar single flagella.
10.2.1 Perform Gram staining
10.2.1.1 Use a compound optical microscope equipped with a calibrated eyepiece micrometer and an oil immersion lens of good resolution to examine the prepared strains. Observe the size and distribution of microorganisms in several fields of view.
10.2.1.2 The strains prepared by staining shall be Gram-negative, short rod-shaped bacteria with a size of (0.3 µm ~ 0.4 µm) × (0.6 µm ~ 1.0 µm), which mainly exists in the form of single cells.
10.3 Biochemical properties
lactose broth or sterile physiological saline, so that the test filter membrane per square centimeter can withstand the challenge of at least 107 microorganisms; mix thoroughly.
11 Preparation of bacterial challenge suspension
11.3 Take samples from the prepared Brevundimonas diminuta challenge suspension under sterile conditions.
11.4 Use 0.1% peptone water to dilute the bacterial suspension to a dilution of 10^-6 under sterile conditions.
11.5 Use membrane filtration method or direct plate coating method to conduct two parallel viable bacterial analyses.
11.5.1 For the membrane filtration method, use 1 mL of diluent of dilution 10-4 ~ 10-6 for filtration. Before adding 1.0 mL of ten-fold dilution, first add 50 mL of sterile physiological saline solution to the funnel of the filter holder; after filtering, use 50 mL of sterile physiological saline solution to rinse the funnel wall; remove the analytical filter membrane from the funnel and place it on the agar medium.
11.5.2 For the direct plate coating method, use 0.1 mL of diluent of dilution 10-3, 10-4, 10-5 to directly coat the plate.
11.6 Incubate the membrane filter plate or directly coat the plate at 30 °C ± 2 °C for 48 hours.
11.7 Take a direct coating plate of 30 CFU ~ 300 CFU or a membrane filter plate of 20 CFU ~ 200 CFU to count the colonies and calculate the initial bacterial suspension concentration (CFU/mL).
11.8 Compare the viable bacterial concentration with the direct microscopic count results in 11.1. The number of viable bacteria shall not be less than 25% of the total number of bacteria.
12 Sample and instrument preparation
12.1 When testing the filter membrane material, cut it into a round test sample of phi47 mm and install it into the filter device. When testing a sterilized fluid filter, take the finished product directly for testing, and there is no need to sterilize it before testing.
12.2 Use sterilization paper to respectively wrap the inlet and outlet joints of the test sample filter component (for filter membrane materials), negative control filter component and positive control filter component; sterilize according to the manufacturer's instructions. Sterilization procedures should be confirmed using biological indicators or thermocouples.
If necessary, perform an integrity test on the filter component of the test sample under sterile conditions according to YY/T 0929.1.
13 Test steps
13.1.9 Remove the analysis filter component; evacuate the downstream for 15 seconds; remove all liquid; transfer the membrane from the filter component to the M plate count agar under sterile conditions; incubate at 30 °C ± 2 °C; record the number of colonies at the 72nd hour and on the 7th day.
13.2 Bacterial challenge test and positive control test
13.2.1 Add the required volume of bacterial suspension prepared in Chapter 11 (at least 500 mL for each branch) into the pressure vessel.
13.2.2 Close valve C and adjustable valves A, B, C and D, and open valves A and B.
13.2.3 Pressurize the pressure vessel to 200 kPa.
13.2.4 Slowly open the adjustable valve D to allow the challenge bacteria suspension to fill the test sample filter assembly, the positive control filter assembly and their downstream analysis filter assemblies. Exhaust air from each filter assembly into a suitable disinfectant. When each filter assembly is filled with liquid, close its exhaust valve.
13.2.6 Open adjustable valve D, and use adjustable valves A and B to adjust the flow rate to an effective filtration area of 2 mL/min ~ 4 mL/min per square centimeter of the test filter membrane and the positive control filter membrane.
13.2.7 When all liquid filtration is completed, close valves A and B and adjustable valves A and B.
13.2.8 Close the air regulator and release the pressure in the container.
13.2.9 Remove each branch analysis filter assembly; evacuate the downstream for 15 seconds; remove all liquid; transfer the membrane from the filter assembly to the M plate count agar under sterile conditions; incubate at 30 °C ± 2 °C; record the number of colonies at the 72nd hour and on the 7th day.
13.2.10 Identify whether each colony is Brevundimonas diminuta or contaminating bacteria (Part 10).
13.2.5 Open adjustable valves A and B
13.3 Integrity test
After the challenge test is completed, if necessary, perform an integrity test on the test sample filter component according to YY/T 0929.1.
14 Result expression
14.1 Identification of filters
Report the membrane/filter manufacturer's name, nominal pore size, effective filtration area and other relevant data.
14.2 Operating conditions
Report pressure, differential pressure, temperature, flow and other relevant parameters.
14.3 Challenge bacteria count
Report the bacterial concentration determined in step 11.7, and calculate and report the total bacterial count in the challenge suspension.
14.4 Number of bacteria in filtrate
14.4.1 Control
Report the number of colonies observed on the positive and negative control analysis filters.
14.4.2 Test sample
Report the number of colonies observed on the analysis filter membrane for the test sample. Report each colony as Brevundimonas diminuta or contaminating bacteria.
14.5 Filter integrity
If applicable, report the parameters and results of the integrity test in 12.1 and 13.3; indicate whether the filter can pass the integrity test; explain the basis for the judgment.
14.6 Filtration performance
Calculate and report the log reduction value.
14.7 Results evaluation
The test is invalid when bacterial colonies appear on the negative control analysis filter or non-test microorganisms appear on the test analysis filter.
When the test sample analysis shows that no bacterial colonies appear on the filter membrane and the positive control is positive, judge that the sterilization requirements are met. […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 19 pages — is available in the English PDF.
Referenced standards
Normative references
Cited by
- YY 0286.1-2019Infusion sets for special purpose - Part 1: Infusion sets for single use with micropore filters
- YY/T 1648-2019Methods of establishing correlation between bubble point pressure and bacterial retention ability of filters for medical infusion equipments
- GB/T 36118-2018Filter elementsof pleated polytetrafluoroethylene microfiltration membrane for gas sterilizing
- GB/T 36138-2018Flat-plate microfiltration membrane of polytetrafluoroethylene for sterilizing
- YY/T 1551.2-2017Air filters for medical infusion and transfusion equipments - Part 2: Liquid bacterial retention test method
- YY/T 0929.1-2014Sterilizing-grade filters for medical infusion equipments - Part 1: Integrity test for fluid filters
Similar standards
How to Download YY/T 0918-2014
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 6682-2008 — Water for analytical laboratory use - Specification and test methods
YY/T 0929.1-2014 — Sterilizing-grade filters for medical infusion equipments - Part 1: Integrity test for fluid filters
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
Secure payment via Stripe
Payments accepted
YY/T 0918-2014
$210.00